Correlation Between ABVC Biopharma and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on ABVC Biopharma and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Pasithea Therapeutics.
Diversification Opportunities for ABVC Biopharma and Pasithea Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ABVC and Pasithea is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between ABVC Biopharma and Pasithea Therapeutics
Given the investment horizon of 90 days ABVC Biopharma is expected to generate 1.12 times more return on investment than Pasithea Therapeutics. However, ABVC Biopharma is 1.12 times more volatile than Pasithea Therapeutics Corp. It trades about -0.02 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.03 per unit of risk. If you would invest 620.00 in ABVC Biopharma on December 12, 2024 and sell it today you would lose (554.50) from holding ABVC Biopharma or give up 89.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
ABVC Biopharma vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| ABVC Biopharma |
| Pasithea Therapeutics |
ABVC Biopharma and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ABVC Biopharma and Pasithea Therapeutics
The main advantage of trading using opposite ABVC Biopharma and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| ABVC Biopharma vs. Indaptus Therapeutics | ||
| ABVC Biopharma vs. Pasithea Therapeutics Corp | ||
| ABVC Biopharma vs. Forte Biosciences | ||
| ABVC Biopharma vs. Akari Therapeutics PLC |
| Pasithea Therapeutics vs. Nutriband Warrant | ||
| Pasithea Therapeutics vs. MediciNova | ||
| Pasithea Therapeutics vs. Virax Biolabs Group | ||
| Pasithea Therapeutics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |